Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis.

Kim EK, Jeon I, Seo H, Park YJ, Song B, Lee KA, Jang Y, Chung Y, Kang CY. Tumor-derived osteopontin suppresses antitumor immunity by promoting extramedullary myelopoiesis. Cancer Res. 2014 Nov 15; 74(22):6705-16.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.